Afimkibart — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07-22 in 30d
ESTIMATED |
READOUT
A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participa
Phase 2 · Atopic Dermatitis |
Hoffmann-La Roche | Afimkibart |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|